buthionine sulfoximine has been researched along with Cancer of Prostate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiguchi, Y; Kikuchi, E; Murai, M; Nakashima, J; Ohigashi, T; Oya, M | 1 |
| Hescheler, J; Sauer, H; Schallenberg, M; Wartenberg, M | 1 |
| Hori, S; Kakehi, Y; Kakizuka, A; Maeda, H; Ogawa, O; Ohizumi, H; Segawa, T | 1 |
| Mickisch, GH; Oomen, MA; Sonneveld, P; van Brussel, JP; Vossebeld, PJ; Wiemer, EA | 1 |
| Canada, A; Herman, L; Kidd, K; Robertson, C; Trump, D | 1 |
| Mulcahy, RT; Ripple, M; Wilding, G | 1 |
| Dagdanova, A; Hescheler, J; Sauer, H; Wartenberg, M | 1 |
| Bäumer, AT; Hescheler, J; Ling, FC; Petrat, K; Sauer, H; Schallenberg, M; Wartenberg, M | 1 |
| Stearns, ME; Tew, KD; Woodworth, A | 1 |
9 other study(ies) available for buthionine sulfoximine and Cancer of Prostate
| Article | Year |
|---|---|
Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer.
Topics: Apoptosis; Buthionine Sulfoximine; Diethylstilbestrol; Glutathione; Humans; Male; Oligodeoxyribonucleotides, Antisense; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tumor Cells, Cultured | 2003 |
Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids.
Topics: Antioxidants; Apoptosis; Arginine; Benzoates; Buthionine Sulfoximine; Caspase 3; Caspases; Enzyme Inhibitors; Epidermal Growth Factor; Fluorescein; Free Radical Scavengers; Humans; Hydrogen Peroxide; Imidazoles; Immunoenzyme Techniques; Indicators and Reagents; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured; Vitamin E | 2003 |
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oxides; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2004 |
Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine.
Topics: Blotting, Western; Buthionine Sulfoximine; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Glutathione; Humans; Leukotriene Antagonists; Male; Multidrug Resistance-Associated Proteins; Propionates; Prostatic Neoplasms; Quinolines | 2004 |
Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.
Topics: Buthionine Sulfoximine; Cell Survival; Glutathione; Humans; Male; Melphalan; Methionine Sulfoximine; Prostatic Neoplasms; Tumor Cells, Cultured | 1993 |
Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Buthionine Sulfoximine; Cell Division; Dose-Response Relationship, Drug; Drug Resistance; Glutathione; Glutathione Transferase; Humans; Male; Melphalan; Methionine Sulfoximine; Prostatic Neoplasms; Tumor Cells, Cultured | 1993 |
Redox-regulation of intrinsic prion expression in multicellular prostate tumor spheroids.
Topics: Antioxidants; Buthionine Sulfoximine; Catalase; Enzyme Inhibitors; Fluorescent Dyes; Free Radical Scavengers; Gene Expression Regulation; Glutamate-Cysteine Ligase; Glutathione; Humans; Hydrogen Peroxide; Male; Oxidation-Reduction; Prions; Prostatic Neoplasms; Reactive Oxygen Species; Superoxide Dismutase; Tumor Cells, Cultured; Vitamin K | 1999 |
Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Drug Resistance, Multiple; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Kinetics; Liver Neoplasms; Male; MAP Kinase Signaling System; Melanoma; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein-Tyrosine Kinases; Reactive Oxygen Species; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |
Relationship of glutathione depletion and inhibition of glutathione-S-transferase activity to the antimitotic properties of estramustine.
Topics: Buthionine Sulfoximine; Cell Line; Cell Survival; Drug Synergism; Estramustine; Glutathione; Glutathione Transferase; Humans; Male; Metaphase; Methionine Sulfoximine; Mitosis; Mitotic Index; Nitrogen Mustard Compounds; Prostatic Neoplasms; Tumor Stem Cell Assay | 1986 |